Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland seeks a part time (70%), fixed-term researcher to March 2028. The role focuses on nanotechnology and cancer immunotherapy, with responsibilities spanning research, supervision, and service activities.
Ideal candidates will have near-completion of a PhD in nanotechnology, nanomedicine, or immunology, a growing research profile, publications in refereed journals, and a track record of obtaining